NanoViricides Inc. (NNVC)

[arvitar]

Seymour probably did believe the poorly spoken chemical engineer with no significant publications, 12 years ago.

But after a decade, did Seymour still believe?

Did he ever really believe he had a platform that could create a new drug for any viral infection in a few weeks?

Did he continue to believe after a decade of failure?

On Jan 2016, Seymour had ELEVEN well-compensated years of experience to help him gauge his optimism. But what did he tell investors?

Too bad he didn't defer salary for stock options, as any overly optimistic incompetent bungler would have done.

"Schedule Reminder

As noted by NNVC in the Jan 2016 Biotech Showcase concerning the lead Herpescide candidate:

May - July: Univ testing to select optimum candidate complete
August - Sept: TOX prep complete
Nov - Dec: TOX package complete
Dec - Feb: Human trials begin"